"ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
As AI’s role in drug design advances rapidly, Chinese start-ups are ramping up fundraising efforts
China is seeing a fresh fundraising boom for AI drug developers, with start-ups including a ByteDance spin-off raising hundreds of millions of dollars this week as investors rush to back domestic challengers to Anthropic and Isomorphic Labs."
Framing: assertive ·
First seen: 2026-09-18 ·
Last seen: 2026-09-18 ·
Spread: 1 articles